Literature DB >> 10636582

Primary malignant melanoma of the urinary bladder associated with widespread metastases.

H M Tainio1, T M Kylmälä, H K Haapasalo.   

Abstract

Malignant melanoma in the urinary tract is very rare. Tumours found in the urinary bladder are usually metastatic. Some ten cases of primary malignant melanoma have been described in the literature, and in only a few of those has a primary bladder melanoma with many distant metastases and rapid fatal outcome been reported. For the first time in Finland, we present a case of primary malignant bladder melanoma associated with widespread metastases.

Entities:  

Mesh:

Year:  1999        PMID: 10636582     DOI: 10.1080/003655999750017086

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  5 in total

1.  Malignant melanoma of the bladder: A case report.

Authors:  Hamide Sayar; Seyda Erdogan; Fulya Adamhasan; Esma Gurbuz; Mehmet Fatih Inci
Journal:  Can Urol Assoc J       Date:  2014 Jan-Feb       Impact factor: 1.862

Review 2.  Melanoma of the urinary bladder: a review of the literature.

Authors:  Anthony Kodzo-Grey Venyo
Journal:  Surg Res Pract       Date:  2014-01-12

3.  Metastatic Melanoma to the Urinary Bladder of Ocular Origin Accompanied with Primary Cutaneous Melanoma: Diagnostic Challenge-A Report of a Case.

Authors:  Constantine Theocharides; Kyriakos Chatzopoulos; Dimitrios Papanikolaou; Vasileios Siokas; Ioannis Amplianitis; Athanasios Papanikolaou
Journal:  Case Rep Pathol       Date:  2017-09-11

4.  Primary Malignant Melanoma of the Bladder: A Rare Case Report in Asia and Review of the Literature.

Authors:  Tanan Bejrananda; Anupong Sawasdee; Sarayuth Boonchai; Monthira Tanthanuch
Journal:  Res Rep Urol       Date:  2021-12-14

Review 5.  Primary melanoma of the bladder: case report and review of the literature.

Authors:  Jin-Dong Dai; Ben He; Zhi-Hong Liu; Ming Shi; Peng-Fei Shen
Journal:  World J Surg Oncol       Date:  2022-09-07       Impact factor: 3.253

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.